Paltusotine

N/A

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NamePaltusotine
Drug Alias NamePALSONIFYCRN-00808
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin receptor 2 agonists
TargetsSomatostatin receptor 2
Therapy Area/IndicationsDiarrheaAcromegalyPancreatic Neoplasms +[10
Global Approved IndicationsAcromegaly
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/09/25
Country/TerritoryBelgiumBulgariaCanada +[29
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesCrinetics Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDiarrheaAcromegalyPancreatic Neoplasms +[10
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG